FONT-SIZE Plus   Neg

Safeguard Scientifics To Realize Addl Proceeds From Lilly's Acquisition Of Avid

Safeguard Scientifics, Inc. (SFE) said it expects to receive an additional $5.6 million in proceeds from Eli Lilly and Co.'s (LLY) acquisition of former partner company Avid Radiopharmaceuticals, Inc., which took place in December 2010.

Under terms of the deal, Eli Lilly acquired all outstanding shares of Avid for an upfront payment of $300 million. This generated initial net proceeds of $32.3 million for Safeguard. In addition, Safeguard recently received $3.4 million, which had been held in escrow.

On April 6, 2012, Lilly and Avid Radiopharmaceuticals announced that the FDA approved Amyvid, a radioactive diagnostic agent indicated for brain imaging of beta-amyloid plaques in patients with cognitive impairment who are being evaluated for Alzheimer's Disease and other causes of cognitive decline. The achievement of this milestone triggered the payment of $5.6 million in additional proceeds to Safeguard, increasing expected total net proceeds to $41.3 million and a 3.4x cash-on-cash return.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
It looks like 2016 is going to be a relatively lackluster year in terms of new drug approvals. Only 18 new molecular entity drugs have been approved year-to-date compared to 32 approved during the same time frame last year. Apple Inc. plans to launch a new guide for Apple TV during a product event in California today, according to Recode. While major video partners have signed up to be a part of the new Apple TV guide, Netflix Inc. will reportedly not be participating. Wal-Mart Stores Inc. is gearing up for the upcoming holiday season by deploying an army of Holiday Helpers to help customers get through the checkout process faster during the busy period. The retailer has also increased the amount of products available through its Pickup service, lowered the price on thousand of items, and plans to expand the online assortment in the coming months.
comments powered by Disqus
Follow RTT